WuXi Biologics touches 1-1/2-year high on robust earnings forecast

WuXi Biologics (Cayman)

24/07/2025 04:33

** Shares of WuXi Biologics (Cayman) Inc 2269.HK jump 4.9% to HK$30.15, their highest since January 2024, and on course for a third consecutive session of gains

** Stock set for the biggest one-day pct gain since June 9, if current gains hold

** Co expects H1 revenue to increase 16% y/y, profit attributable to equity shareholders to rise 56% and gross profit margin to expand 3.6%

** The Hang Seng Biotech Index .HSHKBIO rises 1.1%, the benchmark Hang Seng Index .HSI adds 0.7%

** YTD, stock up 70.6%

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))